| 高雄醫學大學 |
2005 |
Alteration of protein kinase C isoforms expressions in various regions of rat ventricles during sepsis
|
梁馨仁;許勤;許勝光;呂勝義;楊瑞成;楊秀蘭 ; Liang HJ;Hsu C;Hsu HK;Lue SI;Yang RC;Yang SL |
| 高雄醫學大學 |
2005 |
Role of cAMP-response element-binding protein phosphorylation in hepatic apoptosis under protein kinase C alpha suppression during sepsis.
|
謝雅晶;饒曉菁;許勝光;黃麗如;許勤 ; Hsieh YC;Chen YH;Jao HC;Hsu HK;Huang LJ;Hsu C |
| 高雄醫學大學 |
2005 |
Role of cAMP-response element-binding protein phosphorylation in hepatic apoptosis under protein kinase C alpha suppression during sepsis.
|
陳彥旭; Hsieh, YC;Chen, YH;Jao, HC;Hsu, HK;Huang, LJ;Hsu, C |
| 國立臺灣大學 |
2005 |
Fractionation and identification of pparα activators in the oxidized frying oil
|
Hsu, C; Chao, PM; Kuo, YH; Huang, C-j* |
| 國立臺灣大學 |
2005 |
A Question of Trust-An Economics Analysis of Quality Standards in Certification Services Market
|
Backhouse, J; Hsu, C; Tseng, J; Baptista, J |
| 臺大學術典藏 |
2005 |
Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factors
|
Cheng A.-L.; Hsieh F.-J.; Wu C.-Y.; Chen L.-T.; CHIUNG-NIEN CHEN; Hsu C.; Hsu C.;Chiung-Nien Chen;Chen L.-T.;Wu C.-Y.;Hsieh F.-J.;Cheng A.-L. |
| 國立臺灣大學 |
2004-12 |
Use of power Doppler sonography and circulating angiogenic factors to assess the anti-angiogenic effect of thalidomide in hepatocellular carcinoma.
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Hsieh, FJ; Cheng, AL |
| 國家衛生研究院 |
2004-10-18 |
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
|
Shen, YC; Hsu, C; Chen, JY; Cheng, AL |
| 國立臺灣大學 |
2004-10-05 |
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
|
Shen, Y.C.; Hsu, C.; Chen, J.Y.; Cheng, A.L. |
| 國家衛生研究院 |
2004-10 |
Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of hepatocellular carcinoma
|
Cha'ang, H;Lien, P;Tsen, S;Hsu, C;Shih, T |
| 國家衛生研究院 |
2004-07 |
Recent advances in non-surgical treatment for advanced hepatocellular carcinoma
|
Hsu, C;Cheng, JCH;Cheng, AL |
| 國家衛生研究院 |
2004-07 |
Comparison of the antitumor activity of thalidomide between hepatitis B (HBV)and hepatitis C (HCV)-related hepatocellular carcinoma (HCC)
|
Hsu, C;Chen, LT;Lai, MY;Yeh, KH;Lee, PH;Cheng, AL |
| 國家衛生研究院 |
2004-05-04 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu, C; Shen, YC; Yang, CH; Yeh, KH; Lu, YS; Hsu, CH; Liu, HT; Li, CC; Chen, JS; Wu, CY; Cheng, AL |
| 國立臺灣大學 |
2004-05 |
Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
|
Lu, YS; Hsu, C; Li, CC; Kuo, SH; Kun-Huei, Yeh; Yang, CH; Hsu, CH; Wu, CY; Cheng, AL. |
| 國立臺灣大學 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 臺大學術典藏 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C;Shen YC;Yang CH;Kun-Huei Yeh;Lu YS;Hsu CH;Liu HT;Li CC;Chen JS;Wu CY;Cheng AL; Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 臺北醫學大學 |
2004 |
Functional domain and motif analysis of androgen receptor coregulator ARA70 and its differential expression in prostate cancer
|
葉劭德; Hu YC; Yeh S; Yeh SD; Sampson ER; Huang J; Li P; Hsu C; Ting HJ; Lin HK; Wang L; Kim E; Ni J; Chang C |
| 臺北醫學大學 |
2004 |
Introduction of prototype for Stroke Prevention Center.
|
邱弘毅; Chiou HY;Chiu WT;Chen YH;Hsieh YC;Hsu C; |
| 臺大學術典藏 |
2004 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; CHIH-HUNG HSU; Liu H.-T.; Hsu C.; Hsu C.;Shen Y.-C.;Yang C.-H.;Yeh K.-H.;Lu Y.-S.;Chih-Hung Hsu;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Cheng A.-L.; Wu C.-Y.; Li C.-C.; Chen J.-S. |
| 國家衛生研究院 |
2003-12 |
Factors contributing to health behaviors among the elderly in Taiwan
|
Hsu, C;Hsu, H;Shu, C;Shih, Y;Tai, T |
| 國立臺灣大學 |
2003-12 |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma.
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Yang, PM; Lai, MY; Lee, PH; Cheng, AL |
| 國家衛生研究院 |
2003-11 |
Use of power Doppler sonography and circulating angiogenic factors to assess the potential antiangiogenic effect of thalidomide in hepatocellular carcinoma
|
Hsu, C;Chen, HN;Chen, LT;Wu, CY;Hsieh, FJ;Cheng, AL |
| 國家衛生研究院 |
2003-10 |
An investigation of gradient-based reconstruction algorithms for statistical PET transmission imaging
|
Chang, M;Hsu, C |
| 國立臺灣大學 |
2003-01 |
Rejoinder for “Hsu C, et al. survival-weighted health profile for long-term survivors of acute myelogenous leukemia”.
|
Hsu, C.; Wang, J. D.; Yao, G.; Tang, G. L. |
| 國家衛生研究院 |
2003 |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Yang, PM; Lai, MY; Lee, PH; Cheng, AL |
